# A Study on a Blood-based Dual-target Test for CRC Detection

> **NCT05508503** · — · COMPLETED · sponsor: **Changhai Hospital** · enrollment: 1378 (actual)

## Conditions studied

- Colorectal Cancer
- Colorectal Adenoma

## Interventions

- **DIAGNOSTIC_TEST:** Test of methylated NTMT1 and MAP3K14-AS1
- **DIAGNOSTIC_TEST:** FIT

## Key facts

- **NCT ID:** NCT05508503
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-21
- **Primary completion:** 2023-08-11
- **Final completion:** 2023-08-11
- **Target enrollment:** 1378 (ACTUAL)
- **Last updated:** 2024-02-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05508503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05508503, "A Study on a Blood-based Dual-target Test for CRC Detection". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT05508503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*